JP2008540658A5 - - Google Patents

Download PDF

Info

Publication number
JP2008540658A5
JP2008540658A5 JP2008512390A JP2008512390A JP2008540658A5 JP 2008540658 A5 JP2008540658 A5 JP 2008540658A5 JP 2008512390 A JP2008512390 A JP 2008512390A JP 2008512390 A JP2008512390 A JP 2008512390A JP 2008540658 A5 JP2008540658 A5 JP 2008540658A5
Authority
JP
Japan
Prior art keywords
methyl
thio
bis
hydrazide amide
organic solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008512390A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008540658A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/018653 external-priority patent/WO2006124736A2/en
Publication of JP2008540658A publication Critical patent/JP2008540658A/ja
Publication of JP2008540658A5 publication Critical patent/JP2008540658A5/ja
Pending legal-status Critical Current

Links

JP2008512390A 2005-05-16 2006-05-11 ビス(チオ−ヒドラジドアミド)塩の合成 Pending JP2008540658A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68126305P 2005-05-16 2005-05-16
PCT/US2006/018653 WO2006124736A2 (en) 2005-05-16 2006-05-11 Synthesis of bis(thio-hydrazide amide) salts

Publications (2)

Publication Number Publication Date
JP2008540658A JP2008540658A (ja) 2008-11-20
JP2008540658A5 true JP2008540658A5 (cg-RX-API-DMAC7.html) 2009-06-25

Family

ID=37057197

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008512390A Pending JP2008540658A (ja) 2005-05-16 2006-05-11 ビス(チオ−ヒドラジドアミド)塩の合成

Country Status (16)

Country Link
US (1) US7709683B2 (cg-RX-API-DMAC7.html)
EP (1) EP1888520A2 (cg-RX-API-DMAC7.html)
JP (1) JP2008540658A (cg-RX-API-DMAC7.html)
KR (1) KR20080008399A (cg-RX-API-DMAC7.html)
CN (1) CN101223133B (cg-RX-API-DMAC7.html)
AU (1) AU2006247470B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0611262A2 (cg-RX-API-DMAC7.html)
CA (1) CA2607890A1 (cg-RX-API-DMAC7.html)
IL (1) IL187056A (cg-RX-API-DMAC7.html)
MX (1) MX2007014314A (cg-RX-API-DMAC7.html)
NO (1) NO20075707L (cg-RX-API-DMAC7.html)
NZ (1) NZ563124A (cg-RX-API-DMAC7.html)
RU (1) RU2407734C2 (cg-RX-API-DMAC7.html)
TW (1) TWI387579B (cg-RX-API-DMAC7.html)
WO (1) WO2006124736A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200709395B (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI252847B (en) * 2001-07-10 2006-04-11 Synta Pharmaceuticals Corp Synthesis of taxol enhancers
TWI297335B (en) 2001-07-10 2008-06-01 Synta Pharmaceuticals Corp Taxol enhancer compounds
TWI332943B (en) * 2001-07-10 2010-11-11 Synta Pharmaceuticals Corp Taxol enhancer compounds
TWI330079B (en) 2003-01-15 2010-09-11 Synta Pharmaceuticals Corp Treatment for cancers
ES2430373T3 (es) * 2004-06-23 2013-11-20 Synta Pharmaceuticals Corp. Sales de bis(tio-hidrazida amida) para tratamiento de cánceres
CA2587598A1 (en) * 2004-11-19 2006-05-26 Synta Pharmaceuticals Corp. Bis(thio-hydrazide amides) for increasing hsp70 expression
EP1877048A1 (en) 2005-04-15 2008-01-16 Synta Pharmaceuticals Corporation Combination cancer therapy with bis(thiohydrazide) amide compounds
CA2603314A1 (en) * 2005-04-15 2006-10-26 Synta Pharmaceuticals Corp. Methods of increasing natural killer cell activity for therapy
AU2006279891B2 (en) * 2005-08-16 2010-03-11 Synta Pharmaceuticals Corp. Bis(thio-hydrazide amide) formulation
AU2007288338B2 (en) 2006-08-21 2012-05-03 Synta Pharmaceuticals Corp. Compounds for treating proliferative disorders
JP2010501558A (ja) * 2006-08-21 2010-01-21 シンタ ファーマシューティカルズ コーポレーション 癌を治療するためのビス(チオヒドラジドアミド)との組み合わせ
EP2063878A2 (en) * 2006-08-21 2009-06-03 Synta Pharmaceuticals Corporation Bis(thiohydrazide amides) for use in preventing or delaying the recurrence of melanoma
WO2008024305A2 (en) * 2006-08-21 2008-02-28 Synta Pharmaceuticals Corp. Bis (thiohydrazide amides) for treating melanoma
WO2008027445A2 (en) * 2006-08-31 2008-03-06 Synta Pharmaceuticals Corp. Combination with bis(thiohydrazide amides) for treating cancer
US9498528B2 (en) * 2006-09-13 2016-11-22 Genzyme Corporation Treatment of multiple sclerosis (MS)
WO2008033494A2 (en) 2006-09-15 2008-03-20 Synta Pharmaceuticals Corp. Purification of bis(thiohydrazide amides)
WO2009064374A2 (en) 2007-11-09 2009-05-22 Synta Pharmaceuticals Corp. Oral formulations of bis(thiohydrazide amides)
US8581004B2 (en) 2008-02-21 2013-11-12 Synta Pharmaceuticals Corp. Compounds for treating proliferative disorders
WO2009123704A2 (en) * 2008-03-31 2009-10-08 Synta Pharmaceuticals Corp. Process for preparing bis(thiohydrazide amides)
KR20110081300A (ko) 2008-10-22 2011-07-13 신타 파마슈티칼스 코프. 비스[티오하이드라자이드 아미드] 화합물의 전이금속 복합물
US9174935B2 (en) 2008-10-22 2015-11-03 Synta Pharmaceuticals Corp. Transition metal complexes of bis[thiohydrazide amide] compounds
US8525776B2 (en) * 2008-10-27 2013-09-03 Lenovo (Singapore) Pte. Ltd Techniques for controlling operation of a device with a virtual touchscreen
US8680100B2 (en) 2008-12-01 2014-03-25 Synta Pharmaceuticals Corp. Sulfonylhydrazide compounds for treating proliferative disorders
WO2011069159A2 (en) 2009-12-04 2011-06-09 Synta Pharmaceuticals Corp. Bis[thiohydrazide amide] compounds for treating leukemia
EP2560627A1 (en) 2010-04-20 2013-02-27 Synta Pharmaceuticals Corp. Use of bis [thiohydrazide amide]compounds such as elesclomol for treating cancers

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2097737A5 (en) 1970-07-14 1972-03-03 Berlin Chemie Veb Virustatic 4-substd 1-acylthiosemicarbazides -from carboxylic acid - hydrazide and isothiocyanates or from carboxylic acid chloride and 4-
DE2037257A1 (en) 1970-07-28 1972-02-03 Farbwerke Hoechst AG, vorm. Meister Lucius & Brüning, 6000 Frankfurt Poly-(5-amino-1,3,4-thiadiazol-2-yl) derivs prepn - intermediates for drug and polymer prodn
US4012360A (en) 1973-12-03 1977-03-15 Ciba-Geigy Corporation Bis-salicyloyl-dicarboxylic acid dihydrazides as stabilizers for polyolefines
JPS5091056A (cg-RX-API-DMAC7.html) 1973-12-17 1975-07-21
US6013836A (en) 1992-02-28 2000-01-11 Rohm And Haas Company Insecticidal N'-substituted-N,N'-disubstitutedhydrazines
FR2697752B1 (fr) 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
EP0851874B1 (en) 1995-09-22 1999-09-15 Novo Nordisk A/S Novel variants of green fluorescent protein, gfp
US6235787B1 (en) 1997-06-30 2001-05-22 Hoffmann-La Roche Inc. Hydrazine derivatives
GB9727524D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Synergistic antitumor composition containing a biologically active ureido compound
TW479053B (en) 1998-10-19 2002-03-11 Agro Kanesho Co Ltd Hydrazineoxoacetamide derivatives and pesticides
ES2161594B1 (es) 1998-12-17 2003-04-01 Servier Lab Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
US6322303B1 (en) 2000-05-12 2001-11-27 David M. John Dunnage bag and method of making same
EP1164126A1 (de) 2000-06-16 2001-12-19 Basf Aktiengesellschaft Salicylsäurehydrazid-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung zur Bekämpfung von Schadpilzen
US6365745B1 (en) 2000-07-14 2002-04-02 Sumika Fine Chemicals Co., Ltd. Method for producing hydrazine derivative
EP1360173A2 (en) 2001-01-25 2003-11-12 Guilford Pharmaceuticals Inc. Trisubstituted carbocyclic cyclophilin binding compounds and their use
US6602907B1 (en) 2001-06-08 2003-08-05 University Of Central Florida Treatment of breast cancer
TWI252847B (en) * 2001-07-10 2006-04-11 Synta Pharmaceuticals Corp Synthesis of taxol enhancers
TWI297335B (en) * 2001-07-10 2008-06-01 Synta Pharmaceuticals Corp Taxol enhancer compounds
TWI332943B (en) * 2001-07-10 2010-11-11 Synta Pharmaceuticals Corp Taxol enhancer compounds
US6924312B2 (en) * 2001-07-10 2005-08-02 Synta Pharmaceuticals Corp. Taxol enhancer compounds
TW200408407A (en) * 2001-11-30 2004-06-01 Dana Farber Cancer Inst Inc Methods and compositions for modulating the immune system and uses thereof
TWI330079B (en) 2003-01-15 2010-09-11 Synta Pharmaceuticals Corp Treatment for cancers
ES2430373T3 (es) * 2004-06-23 2013-11-20 Synta Pharmaceuticals Corp. Sales de bis(tio-hidrazida amida) para tratamiento de cánceres
WO2006033913A2 (en) 2004-09-16 2006-03-30 Synta Pharmaceuticals Corp. Bis (thio-hydrazide amides) for treament of hyperplasia
CA2587598A1 (en) * 2004-11-19 2006-05-26 Synta Pharmaceuticals Corp. Bis(thio-hydrazide amides) for increasing hsp70 expression
EP1877048A1 (en) 2005-04-15 2008-01-16 Synta Pharmaceuticals Corporation Combination cancer therapy with bis(thiohydrazide) amide compounds
CA2603314A1 (en) 2005-04-15 2006-10-26 Synta Pharmaceuticals Corp. Methods of increasing natural killer cell activity for therapy
WO2006113493A2 (en) 2005-04-15 2006-10-26 Synta Pharmaceuticals Corp. Methods of determining cancer prognosis via natural killer cell activity
AU2006279891B2 (en) * 2005-08-16 2010-03-11 Synta Pharmaceuticals Corp. Bis(thio-hydrazide amide) formulation

Similar Documents

Publication Publication Date Title
JP2008540658A5 (cg-RX-API-DMAC7.html)
RU2007144216A (ru) Способ получения бис(тиогидразидамидной) дисоли (варианты)
JP2008504264A5 (cg-RX-API-DMAC7.html)
RU2406722C2 (ru) Соли бис-(тиогидразидамида) для лечения рака
ES2404336T3 (es) Procedimientos para la preparación de compuestos de aminosulfona
Zhu et al. Transition-metal-free cross-coupling of thioethers with aryl (cyano) iodonium triflates: a facile and efficient method for the one-pot synthesis of thiocyanates
JP2008523069A5 (cg-RX-API-DMAC7.html)
JP2010529212A5 (cg-RX-API-DMAC7.html)
JP2011527667A5 (cg-RX-API-DMAC7.html)
GB0418900D0 (en) Novel salt forms
JP2012504608A5 (cg-RX-API-DMAC7.html)
JP2017132814A5 (cg-RX-API-DMAC7.html)
JP2017511321A5 (cg-RX-API-DMAC7.html)
JP2012528813A5 (cg-RX-API-DMAC7.html)
CN106977470A (zh) 一种可见光催化的2‑亚胺噻唑啉类衍生物的合成方法
Ding et al. Synthesis of difluoromethyl and deuterium-labeled difluoromethyl thioethers from aliphatic electrophiles
JP2015504075A5 (cg-RX-API-DMAC7.html)
RU2009111276A (ru) Способ получения 1-(3, 4-дихлорбензил)-5-октилбигуанида или его соли
Morja et al. Multicomponent Approaches Involving Carbon Disulfide
JP2008540414A5 (cg-RX-API-DMAC7.html)
JP2018501268A (ja) チゾキサニドホスフェート及びアルカンスルホネート並びにその医薬用途
RU2013110311A (ru) Синтез соединений тиазолидиндиона
CN109336794A (zh) 一种芳乙烯基三氟甲硫醚类化合物的合成方法
CN103347846A (zh) 制备α-羟基酮化合物的方法
RU2013106503A (ru) Способ получения контрастных агентов